Literature DB >> 2821623

Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21.

J C Lacal1, P de la Peña, J Moscat, P Garcia-Barreno, P S Anderson, S A Aaronson.   

Abstract

The p21 products of ras proto-oncogenes are thought to be important components in pathways regulating normal cell proliferation and differentiation. These proteins acquire transforming properties as a result of activating lesions that convert ras genes to oncogenes in a wide array of malignancies. In Xenopus laevis oocytes, microinjection of transforming ras p21 is a potent inducer of maturation, whereas microinjection of a monoclonal antibody to ras p21 inhibits normal maturation induced by hormones. The phosphoinositide pathway is a ubiquitous system that appears to play a key role in diverse cellular functions. By use of the Xenopus oocyte system, it was possible to quantitate the effects of ras p21 microinjection on individual components of the phosphoinositide pathway. Within 20 minutes of microinjection, levels of phosphatidylinositol 4,5-bisphosphate, inositol 1-phosphate, and inositol bisphosphate increased 1.5- to 2-fold. The most striking effects were on diacylglycerol, which increased 5-fold under the same conditions. In contrast, the normal ras p21 protein induced no detectable alteration in any of the metabolites analyzed. The earliest effects of the transforming p21 on phosphoinositol turnover were observable within 2 minutes, implying a very rapid effect of ras p21 on the enzymes involved in phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821623     DOI: 10.1126/science.2821623

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  H-ras(val12) induces cytoplasmic but not nuclear events of the cell cycle in small Xenopus oocytes.

Authors:  A D Johnson; R J Cork; M A Williams; K R Robinson; L D Smith
Journal:  Cell Regul       Date:  1990-06

Review 2.  GTP-binding proteins and potassium channels involved in synaptic plasticity and learning.

Authors:  T J Nelson; D L Alkon
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Modulation of maturation and ribosomal protein S6 phosphorylation in Xenopus oocytes by microinjection of oncogenic ras protein and protein kinase C.

Authors:  T Kamata; H F Kung
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

Review 4.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

5.  p21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect.

Authors:  J Downward; J de Gunzburg; R Riehl; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways.

Authors:  C B Barrett; R M Schroetke; F A Van der Hoorn; S K Nordeen; J L Maller
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells.

Authors:  H Cai; J Szeberényi; G M Cooper
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 8.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

9.  Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C.

Authors:  D L Chung; P W Brandt-Rauf; I B Weinstein; S Nishimura; Z Yamaizumi; R B Murphy; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts.

Authors:  Y Iwamoto; R Reich; G Nemeth; Y Yamada; G R Martin
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.